Loading...

Kindstar Globalgene Technology, Inc.

9960.HKHKSE
Healthcare
Medical - Care Facilities
HK$1.52
HK$0.02(1.33%)

Kindstar Globalgene Technology, Inc. (9960.HK) Company Profile & Overview

Explore Kindstar Globalgene Technology, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Kindstar Globalgene Technology, Inc. (9960.HK) Company Profile & Overview

Kindstar Global (Beijing) Technology, Inc. provides medical esoteric testing services to hospitals in China. Its services include medical research, drug trial, and translational medicine research services for physicians, medical science and technology institutions, specialty and general hospitals, and pharmaceutical companies. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research laboratories. It provides tests in blood, tumor, and genetics; and cardiovascular, cerebrovascular, infectious, and autoimmune diseases, as well as in internal medicine, surgery, gynecology, pediatrics, and other specialties. The company was founded in 2003 and is headquartered in in Wuhan, China.

SectorHealthcare
IndustryMedical - Care Facilities
CEOShiang Huang

Contact Information

86 40 0736 1666
Biolake D2-1, Wuhan

Company Facts

3,011 Employees
IPO DateJul 16, 2021
CountryCN
Actively Trading

Frequently Asked Questions

;